Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S

Comparing revenue growth: Walgreens vs Ascendis Pharma

__timestampAscendis Pharma A/SWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20141398300076392000000
Thursday, January 1, 20158118000103444000000
Friday, January 1, 20164606000117351000000
Sunday, January 1, 20171530000118214000000
Monday, January 1, 201810581000131537000000
Tuesday, January 1, 201913375000120074000000
Wednesday, January 1, 20206953000121982000000
Friday, January 1, 20217778000132509000000
Saturday, January 1, 202251174000132703000000
Sunday, January 1, 2023266718000139081000000
Monday, January 1, 2024363641000147658000000
Loading chart...

Unveiling the hidden dimensions of data

Revenue Trends: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S

In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding revenue trends is crucial. Walgreens Boots Alliance, Inc., a giant in the retail pharmacy space, has shown a consistent upward trajectory in revenue from 2014 to 2023, with a remarkable 82% increase over the decade. In contrast, Ascendis Pharma A/S, a biopharmaceutical company, has experienced a staggering growth of over 1800% in the same period, albeit from a much smaller base. This stark difference highlights the diverse growth dynamics between established retail giants and emerging biotech firms. Notably, Walgreens' revenue peaked in 2024, while Ascendis saw its highest revenue in 2023, indicating potential market shifts. These insights underscore the importance of strategic positioning and innovation in maintaining competitive advantage in these industries.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025